Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01139528
Other study ID # FASUUS 1529
Secondary ID
Status Completed
Phase N/A
First received May 18, 2010
Last updated April 23, 2015
Start date May 2010
Est. completion date October 2013

Study information

Verified date April 2015
Source Oslo University Hospital
Contact n/a
Is FDA regulated No
Health authority Norway: Ethics Committee
Study type Interventional

Clinical Trial Summary

A multi-site randomized controlled trial where patients are allocated to operative treatment or conservative treatment of fractures of the neck of the 5th metacarpal bone. The study goal is to identify which degree of angular displacement in the fracture that requires operative intervention.


Recruitment information / eligibility

Status Completed
Enrollment 85
Est. completion date October 2013
Est. primary completion date October 2013
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients over 18 years of age with fractures of the neck of the 5th metacarpal bone

Exclusion Criteria:

- Less than 30 degrees of volar angulation in the fracture

- rotational deformity

- pseudoclawing

- intra-articular involvement

- ad latus displacement more than one half of a bone width

- concomitant fractures or soft tissue damage

- admittance more than 14 days after injury

- non-compliant patient (language, drugs, tourist)

- patient who refuses to participate in the study

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
Bouquet pinning of the 5th metacarpal bone
The fracture is reduced under general anesthesia and 2-3 K-pins are introduced in the medullar cavity to keep the fracture in the reduced position

Locations

Country Name City State
Norway Oslo University Hospital Oslo

Sponsors (3)

Lead Sponsor Collaborator
Oslo University Hospital Asker & Baerum Hospital, University Hospital, Akershus

Country where clinical trial is conducted

Norway, 

Outcome

Type Measure Description Time frame Safety issue
Primary Quick-DASH Validated hand function score 6 weeks, 3 months, 1 year, 2 years No
Secondary Patient satisfaction VAS scale 6 weeks, 3 months, 1 year, 2 years No
Secondary Pain VAS scale 1 week, 6 weeks, 3 months, 1 year, 2 years No
Secondary Eq-5d Validated quality of life score 6 weeks, 3 months, 1 year, 2 years No
Secondary Complications All complications are noted 1 week, 6 weeks, 3 months, 1 year, 2 years No
Secondary Sick-leave Days of sick-leave off work 1 week, 6 weeks, 3 months (1 year, 2 years) No
Secondary Range of motion in the joints in the 5th finger measured by hand therapist total active motion 5th finger, totale passive motion 5th finger, active and passive extension and flexion in the 5th MCP-joint 3 months, 1 year, 2 years No
Secondary Grip strength Compared to the non-injured hand 3 months, 1 year, 2 years No
Secondary Angular displacement in fracture measured in lateral x-ray, and shortening in fracture measured in AP view, of the 5th ray of the hand 6 weeks, 1 year No